While it is largely accepted that ATR does not play a role in the cellular response to DNA damage in resting CLL cells, recent data we obtained about the mechanism of activation of deoxycytidine kinase (dCK) led us to reconsider this view. Here, DCK is linked to B-cell chronic lymphocytic leukemia.